What is the appropriate workup and initial management for a patient with a suspected infection of unknown source?

Workup and Management of Suspected Infection of Unknown Source

For patients with suspected infection of unknown source, immediately obtain at least 2 sets of blood cultures (one peripheral, one from any central line if present) and initiate broad-spectrum empiric antimicrobial therapy within 1 hour, while simultaneously pursuing targeted diagnostic imaging based on clinical clues. 1, 2

Initial Assessment and Risk Stratification

Perform rapid clinical evaluation focusing on:

• Hemodynamic stability: Presence of hypotension, tachycardia, altered mental status indicating septic shock
• Organ dysfunction markers: Respiratory distress, oliguria, elevated lactate
• High-risk features: Neutropenia, immunosuppression, prosthetic devices, recent healthcare exposure
• Localizing symptoms: Even subtle ones like new back pain (spondylodiscitis), abdominal tenderness, or skin changes

3, 1, 2

Diagnostic Workup Algorithm

Laboratory Studies (Obtain Immediately)

• Complete blood count with differential
• Blood cultures: Minimum 2 sets from separate sites before antibiotics, but do not delay antibiotics >45 minutes 1, 4
• Lactate level for tissue hypoperfusion assessment
• Creatinine, electrolytes, liver enzymes
• C-reactive protein: Values <128 mg/L may suggest lower likelihood of CT findings, but this alone cannot exclude imaging 5
• Urinalysis and urine culture if any genitourinary symptoms

3, 1, 2

Imaging Strategy

Chest radiograph is mandatory for any respiratory symptoms 3

For patients without obvious source after initial evaluation:

Consider thoraco-abdominal-pelvic CT (TAP-CT) when:

• Patient has leukocytosis, anemia, or elevated absolute neutrophil count 6
• Positive blood cultures without clear source 6
• Persistent fever despite initial workup
• Clinical deterioration

TAP-CT identifies infectious focus in 55% of cases (most commonly pulmonary 46%, bilio-digestive 25%, genitourinary 23%) and detects significant non-infectious findings (malignancy, thrombosis) in 20% 5. No clinical criteria reliably predict normal CT, so maintain low threshold for imaging 5.

[18F]FDG-PET/CT should be considered for:

• Fever of unknown origin (FUO) persisting >3 weeks despite initial workup
• Suspected spondylodiscitis, endocarditis, or metastatic infection
• Diagnostic yield 56-76% with moderate agreement with final diagnosis 7
• Cost-effective when performed early in diagnostic algorithm 7

Empiric Antimicrobial Therapy

Timing: Critical Priority

Administer IV antibiotics within 1 hour of recognizing suspected infection/sepsis 1, 2. Delay in effective therapy directly increases mortality 2.

Initial Regimen Selection

For community-acquired infection without shock:

• Monotherapy with anti-pseudomonal β-lactam:
  • Cefepime, meropenem, imipenem-cilastatin, OR piperacillin-tazobactam 3

For healthcare-associated infection or septic shock:

• Broad-spectrum β-lactam (as above) PLUS
• Consider adding vancomycin if:
  • Suspected catheter-related infection
  • Skin/soft tissue infection visible
  • Pneumonia present
  • Hemodynamic instability
  • Known MRSA colonization or high local prevalence (>10-20%) 3, 8

Do NOT routinely add vancomycin without these specific indications 3

Special Populations

Neutropenic patients (ANC <500):

• High-risk (prolonged neutropenia >7 days, ANC <100): Hospitalize, IV monotherapy with anti-pseudomonal β-lactam 3
• Add aminoglycoside or fluoroquinolone only for complications (hypotension, pneumonia) 3
• Consider empiric antifungal (echinocandin preferred) if fever persists >4-7 days on antibiotics 9, 10

Suspected intra-abdominal source:

• Add metronidazole or use piperacillin-tazobactam for anaerobic coverage 4
• Echinocandin for suspected candidiasis in high-risk patients 4

Penicillin allergy (immediate hypersensitivity):

• Ciprofloxacin + vancomycin OR aztreonam + vancomycin 3

Reassessment at 48-72 Hours

If patient improves and cultures negative:

• Continue antibiotics but consider narrowing spectrum
• Low-risk patients may transition to oral therapy 3, 9

If fever persists despite stability:

• Continue same regimen if clinically stable
• Repeat imaging to evaluate for abscess, deep-seated infection 9
• Consider fungal infection: Add echinocandin (caspofungin, micafungin, anidulafungin) 9, 10
• Consult infectious disease specialist 9, 2

If clinical deterioration:

• Broaden coverage immediately
• Add or change to carbapenem + vancomycin
• Consider resistant organisms (MRSA, VRE, ESBL, KPC) based on local epidemiology 3
• Urgent infectious disease consultation 9

Source Control

Surgical intervention or drainage required for:

• Identified abscesses (after marrow recovery in neutropenic patients) 10
• Necrotizing soft tissue infections 10
• Cholecystitis, cholangitis requiring biliary drainage 4
• Infected prosthetic material 11

Common Pitfalls

• Delaying antibiotics for cultures: Obtain cultures quickly but never delay antibiotics beyond 1 hour 1
• Overuse of vancomycin: Only add for specific indications, not routine empiric coverage 3
• Inadequate imaging: TAP-CT has high yield (67% positive findings) and should not be withheld based on normal labs alone 5
• Ignoring non-infectious causes: Consider drug fever, thrombosis, malignancy, especially if cultures remain negative 2
• Failure to deescalate: Reassess daily and narrow antibiotics once pathogen identified 1